Studies have demonstrated that cancer-specific transcription-induced chimeric RNA-loaded DC-derived exosomes enhance CD8+ T-cell-mediated anticancer immunity and suppress tumour progression in esophageal cancer [64]. The gene discussed is CD8A; the disease is cancer.